Dr. Allbritton obtained her B.S. in physics from Louisiana State University, her Ph.D. in Medical Physics/Medical Engineering from MIT, and her M.D. from the Johns Hopkins University. After postdoctoral fellowship in cell biology at Stanford University, she joined thefaculty of the University of California at Irvine in the Departments of Physiology and Biophysics, Biomedical Engineering, Chemistry, and Chemical Engineering&
MaterialsScience. She moved to UNC-Chapel Hill as the Debreczeny Distinguished Professor in the Department of Chemistry in 2007 followed by a joint appointment in the Department of Pharmacology. In 2009, she was also appointed Professor and Chair of the Department of Biomedical Engineering, a joint department between NCSU and UNC. Dr. Allbritton's research studies, described in over 130 publications, are directed at the development of new technologies to address biomedical problems. This research program has been heavily funded by NIH with over $40 M since 1994. She has received multiple awards including a Beckman Investigator Award, and a Searle Scholar Award and is a Fellow in the American Institute for Medical & Biological Engineering and the AAAS. Dr. Allbritton is the scientific founder of two companies, Protein Simple (valued at $308 M) and Cell Microsystems.
